COVID-19 vaccine for all children and adolescents aged 12-18 years
Our Pediatric Cardiology team is receiving many requests for information regarding the COVID-19 vaccine for children and adolescents aged 12-18 years after the following recommendations and news release over the last few days.
- On May 18, 2021, the Canadian National Advisory Committee on Immunization (NACI) recommended that the Pfizer COVID-19 vaccine should be offered to all children and adolescents aged 12 to 18 years without contraindications to the vaccine (e.g. proven anaphylaxis or a severe allergic reaction with previous exposure to polyethylene glycol, a component of the vaccine, which is very rare).
- On May 19, 2021, the Saskatchewan Health Authority (SHA) issued a News Release, that the eligibility for first dose COVID-19 Immunization will move to age 12 years, effective May 20, 2021.
We have NO information to suggest that eligible children and adolescents with heart disorders aged 12 to 18 years should be treated any differently.
For further information please find the relevant web links below.
- National Advisory Committee on Immunization (NACI) Recommendation, May 18, 2021
- Saskatchewan Health Authority (SHA) New Release, May 19, 2021
- Pfizer-BioNTech COVID-19 Vaccine Information Sheet which is downloadable here from the SHA website
Pfizer-BioNTech COVID-19 Vaccine Information
- Contraindications and Precautions for the Pfizer-BioNTech COVID-19 Vaccine from the NACI website
Pfizer-BioNTech COVID-19 Vaccine Contraindications and Precautions
We will keep you posted as we receive any new updates. If you have any questions or concerns, please contact our team at (306) 844-1235.
Take care and stay healthy,
The Pediatric Cardiology Team, JPCH